Parenteral Drugs (India) (NSE:PDPL) Scaled Net Operating Assets: N/A (As of Mar. 2022)


NSE:PDPL Parenteral Drugs (India) Ltd NSE:PDPL
4 GF Score
Price ₹2.90
View Full Analysis

What is Parenteral Drugs (India) Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Parenteral Drugs (India)'s operating assets for the quarter that ended in Mar. 2022 was ₹4,842.34 Mil. Parenteral Drugs (India)'s operating liabilities for the quarter that ended in Mar. 2022 was ₹12,009.43 Mil. Parenteral Drugs (India)'s Total Assets for the quarter that ended in Dec. 2021 was ₹0.00 Mil. Therefore, Parenteral Drugs (India)'s scaled net operating assets (SNOA) for the quarter that ended in Mar. 2022 was N/A.

Parenteral Drugs (India) Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for Parenteral Drugs (India)'s Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Parenteral Drugs (India) Scaled Net Operating Assets Chart

Parenteral Drugs (India) Annual Data
Trend Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.75 0.44 0.71 0.71 -1.26

Parenteral Drugs (India) Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

NSE:PDPL vs ZTS, CTLT, VTRS: Scaled Net Operating Assets Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Parenteral Drugs (India)'s Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Parenteral Drugs (India) Scaled Net Operating Assets vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Parenteral Drugs (India)'s Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Parenteral Drugs (India)'s Scaled Net Operating Assets falls into.


NSE:PDPL
4GF Score
Parenteral Drugs (India) Ltd NSE:PDPL
Scaled Net Operating Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Parenteral Drugs (India) Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Parenteral Drugs (India)'s Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Mar. 2022 is calculated as

Scaled Net Operating Assets (SNOA)(A: Mar. 2022 )
=(Operating Assets (A: Mar. 2022 )-Operating Liabilities (A: Mar. 2022 ))/Total Assets (A: Mar. 2021 )
=(4842.337-12009.425)/5682.036
=-1.26

where

Operating Assets(A: Mar. 2022 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=4842.338 - 0.001
=4842.337

Operating Liabilities(A: Mar. 2022 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=13081.419 - 1071.994 - 0
=12009.425

Parenteral Drugs (India)'s Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2022 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Mar. 2022 )
=(Operating Assets (Q: Mar. 2022 )-Operating Liabilities (Q: Mar. 2022 ))/Total Assets (Q: Dec. 2021 )
=(4842.337-12009.425)/0
=N/A

where

Operating Assets(Q: Mar. 2022 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=4842.338 - 0.001
=4842.337

Operating Liabilities(Q: Mar. 2022 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=13081.419 - 1071.994 - 0
=12009.425

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Parenteral Drugs (India) Business Description

Address Navlakha Crossing, A. B. Road, Shree Ganesh Chambers, Indore, MP, IND, 452001
Parenteral Drugs (India) Ltd is a pharmaceutical company. It is principally engaged in manufacturing pharmaceutical preparations. The company manufactures products in categories like intravenous (IV) fluids, oncology, anesthesia, and export products. Its IV fluids products include carbohydrates and electrolytes, diuretics, dialysis, and irrigation solution, anti-infective and anti-fungal, and other pharmaceutical products.
4GF Score

Get the complete analysis for NSE:PDPL

Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹2.90
Price